New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
Call 08048982480 90% Response Rate
Send Enquiry
Product Brochure
| Treatment Type | Breast Cancer |
| Dosage Form | Injection |
| Injection Type | Solution |
| Brand | Gemivo |
| Strength | 1 g |
| Composition | Gemcitabine |
| Packaging Size | Vial |
| Form | Injection |
Gemivo 1000mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gemivo 1000mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. Gemivo 1000mg injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemivo 1000mg injection.
View Complete details
Product Brochure
| Strength | 200 mg |
| Dose/Strength | 200 mg |
| Injection Type | Lyophilized Powder |
| Composition | Gemcitabine |
| Packaging Type | Vial |
| Manufacturer | Emcure |
| Usage/Application | Hospital |
| Salt Composition | Gemcitabine Injection |
| Brand Name | Citafine 200mg |
Emcitaben 200 mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Emcitaben 200 mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Emcitaben 200 mg injection.
View Complete details
Product Brochure
| Strength | 200 mg |
| Injection Type | Lyophilized Powder |
| Composition | Gemcitabine |
| Packaging Size | Vial |
| Brand | Gemivo |
| Form | Injection |
| Salt Composition | Gemcitabine Injection |
| Marketer | MEDICAMEN BIOTECH LTD |
Gemivo 200mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gemivo 200mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. Gemivo 200mg injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemivo 200mg injection.
View Complete details
Product Brochure
| Strength | 1000 mg |
| Dose/Strength | 1000 mg |
| Injection Type | Injection |
| Composition | Gemcitabine IP |
| Packaging Type | Vial |
| Manufacturer | Emcure Pharmaceuticals Ltd. |
| Usage/Application | Hospital |
| Salt Composition | Gemcitabine 1gm Injection |
| Country of Origin | India |
View Complete details
Product Brochure
| Strength | 1000 mg |
| Dose/Strength | 1000 mg |
| Injection Type | Lyophilized Powder |
| Composition | Gemcitabine |
| Packaging Type | Vial |
| Manufacturer | SHILPA MEDICARE LTD |
| Usage/Application | Hospital |
| Brand Name | Shilgem Rtu 1000mg |
| Salt Composition | Gemcitabine Injection |
Shilgem Rtu 1000mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Shilgem Rtu 1000mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Shilgem Rtu 1000mg injection.
View Complete details
Product Brochure
| Strength | 200 mg/5.2 ml |
| Injection Type | Injection |
| Composition | Gemcitabine |
| Packaging Size | Vial |
| Brand | Gemwem Rtu |
| Form | Injection |
| Salt Composition | Gemcitabine Injection |
Gemwem Rtu 200mg Injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or were vaccinated before taking this medicine.
Gemwem Rtu 200mg Injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemwem Rtu 200mg Injection.
View Complete details
Product Brochure
| Strength | 1000 mg |
| Injection Type | Injection |
| Composition | Gemcitabine |
| Packaging Size | Vial |
| Brand | Gemwem |
| Form | Injection |
Gemwem 1gm Injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gemwem 1gm Injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemwem 1Gm Injection.
View Complete details
Product Brochure
| Strength | 1000 mg |
View Complete details
Product Brochure
| Strength | 200 mg |
View Complete details
Product Brochure
| Strength | 1400 mg |
View Complete details